Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Impact of Physical Exercise on Quality of Life in Patients With Inflammatory Bowel Disease - a Pilot Study. [NA]
A completed pilot study evaluating whether structured physical exercise improves quality of life in patients with inflammatory bowel disease…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Trial on Profermin and Fresubin in Ulcerative Colitis [Phase 2, Phase 3]
This clinical trial update announces the completion of Phase 2 and Phase 3 studies evaluating Profermin and Fresubin in patients with ulcera…
-
FDA label_change · 2013-12-16FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for PENTASA (mesalamine) to update the product labeling. The submission was filed by Takeda Pharmace…
-
FDA label_change · 2013-12-16FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for LIALDA (mesalamine) from Takeda Pharmaceuticals America, resulting in updated labeling.
-
CLINICAL_TRIALS withdrawal · 2013-12-13Clinical Trial Update: Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing retard phosphatidylcholine versus mesalazine for achieving remission in ulcerative colitis was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-12-02Clinical Trial Update: Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis [Phase 4]
A Phase 4 trial evaluating MMX mesalamine once daily for maintaining or achieving clinical and endoscopic remission in adults with ulcerativ…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease [Phase 3]
Phase 3 extension study evaluating the safety and efficacy of iron isomaltoside 1000 (Monofer) in subjects with inflammatory bowel disease a…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease [NA]
Open-label clinical trial update for adults with Pyoderma Gangrenosum and inflammatory bowel disease (Crohn's disease and ulcerative colitis…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Fecal Microbiota Transplantation for Ulcerative Colitis [NA]
The clinical trial evaluating fecal microbiota transplantation for ulcerative colitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating golimumab for moderately to severely active ulcerative colitis; the study is completed and results were posted in 2…
-
FDA approval · 2013-10-25FDA Approved: MESALAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Mesalamine from Teva Pharmaceuticals USA, Inc., resulting in changes to its labeling per the…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis
This is a completed clinical trial evaluating the tolerability of Pentasa Sachet (mesalamine) in patients with Ulcerative Colitis.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Wireless Capsule Endoscopy in Ulcerative Colitis [Phase 3]
A Phase 3 clinical trial evaluating wireless capsule endoscopy for Ulcerative Colitis has completed.
-
FDA approval · 2013-08-28FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for LIALDA (mesalamine) filed by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis [Phase 1]
This report notes the completion of a Phase 1 clinical trial evaluating a leukapheresis-based treatment for ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease
This clinical trial update reports adherence to the Mesalamine profile in patients with inflammatory bowel disease (ulcerative colitis and C…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle [Phase 4]
Phase 4 clinical trial evaluating ciprofloxacin in combination with Escherichia coli Nissle 1917 for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating safety and efficacy of Interferon-Beta-1a (Rebif) in treating acute symptoms of Ulcerative Colitis; study completed…
-
CLINICAL_TRIALS withdrawal · 2013-08-02Clinical Trial Update: Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis [Phase 1]
Withdrawn Phase 1 clinical trial evaluating pharmacodynamics and safety of HGS1025 in patients with Ulcerative Colitis.
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis [Phase 1, Phase 2]
A Phase 1 and Phase 2 clinical trial is evaluating allogeneic adipose tissue-derived mesenchymal stem cells to induce remission in ulcerativ…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis [Phase 1]
A Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of AMG 181 in healthy subjects and subjects with Ulce…
-
FDA approval · 2013-07-23FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Pentasa (mesalamine) from Takeda Pharmaceuticals America, Inc. The action involves an update to …
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Evaluation Of The Pillcam™ Colon Capsule Endoscopy (Pcce-2) In Pediatric Ulcerative Colitis
Clinical trial evaluating the PillCam Colon Capsule Endoscopy for pediatric ulcerative colitis has completed.
-
CLINICAL_TRIALS withdrawal · 2013-06-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis [Phase 2]
A Phase 2 trial evaluating GSK1605786 for active ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS research · 2013-06-19Clinical Trial Update: A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
A retrospective data collection study evaluating compression anastomosis with the ColonRing device, sponsored by novoGI. The current trial s…